Literature DB >> 5492474

Absorption and excretion of 35S dapsone in dermatitis herpetiformis.

J O Alexander, E Young, T McFadyen, N G Fraser, W P Duguid, E M Meredith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5492474     DOI： 10.1111/j.1365-2133.1970.tb15756.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  8 in total

1.  The pharmacokinetics of dapsone after oral administration to healthy volunteers.

Authors:  F A Pieters; J Zuidema
Journal:  Br J Clin Pharmacol       Date:  1986-10       Impact factor: 4.335

2.  Bioactivation of dapsone to a cytotoxic metabolite by human hepatic microsomal enzymes.

Authors:  M D Coleman; A M Breckenridge; B K Park
Journal:  Br J Clin Pharmacol       Date:  1989-10       Impact factor: 4.335

Review 3.  Drug absorption in gastrointestinal disease with particular reference to malabsorption syndromes.

Authors:  R L Parsons
Journal:  Clin Pharmacokinet       Date:  1977 Jan-Feb       Impact factor: 6.447

Review 4.  Clinical pharmacokinetics of dapsone.

Authors:  J Zuidema; E S Hilbers-Modderman; F W Merkus
Journal:  Clin Pharmacokinet       Date:  1986 Jul-Aug       Impact factor: 6.447

Review 5.  Clinical pharmacokinetic considerations in the treatment of patients with leprosy.

Authors:  K Venkatesan
Journal:  Clin Pharmacokinet       Date:  1989-06       Impact factor: 6.447

6.  Enhancement by clofazimine and inhibition by dapsone of production of prostaglandin E2 by human polymorphonuclear leukocytes in vitro.

Authors:  R Anderson
Journal:  Antimicrob Agents Chemother       Date:  1985-02       Impact factor: 5.191

7.  Response of the skin in dermatitis herpetiformis to a gluten free diet, with reference to jejunal morphology.

Authors:  B T Cooper; E Mallas; M D Trotter; W T Cooke
Journal:  Gut       Date:  1978-08       Impact factor: 23.059

8.  In vitro and in vivo effects of dapsone on neutrophil and lymphocyte functions in normal individuals and patients with lepromatous leprosy.

Authors:  R Anderson; E M Gatner; C E van Rensburg; G Grabow; F M Imkamp; S K Kok; A J van Rensburg
Journal:  Antimicrob Agents Chemother       Date:  1981-04       Impact factor: 5.191
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.